Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.

نویسندگان

  • S F Nagueh
  • N M Lakkis
  • Z X He
  • K J Middleton
  • D Killip
  • W A Zoghbi
  • M A Quiñones
  • R Roberts
  • M S Verani
  • N S Kleiman
  • W H Spencer
چکیده

OBJECTIVES This study was undertaken to evaluate the ability of myocardial contrast echocardiography (MCE) to guide the targeted delivery of ethanol during nonsurgical septal reduction therapy (NSRT) and to assess the relation between the MCE risk area and infarct size determined by enzymatic and radionuclide methods. BACKGROUND NSRT with intracoronary ethanol is a new promising treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM). Proper localization and quantification of the septal infarct before ethanol injection are highly desirable. MCE can provide accurate delineation of the vascular territory of the coronary arteries. METHODS Twenty-nine patients with HOCM and maximal medical therapy underwent NSRT. The left ventricular outflow tract (LVOT) gradient by Doppler echocardiography at baseline was 53 +/- 16 mm Hg (mean +/- SD). Before NSRT, MCE was performed in all patients with intracoronary sonicated albumin (Albunex). Diluted sonicated albumin (Albunex) was selectively injected into the septal perforator arteries during simultaneous transthoracic imaging. Immediately after MCE, ethanol was injected into the same vessel. Plasma total creatine kinase (CK), total CK-MB fraction and CK-MB fraction subforms were measured at baseline and serially for 36 h. RESULTS LVOT gradient decreased to 12 +/- 6 mm Hg (p < 0.001) after NSRT. Accurate mapping of the vascular beds of the septal perforators was successfully attained in all patients by MCE. Furthermore, the MCE risk area correlated well with peak CK (r = 0.79, p < 0.001). Six weeks after NSRT, 23 patients underwent myocardial perfusion studies performed with single-photon emission computed tomography (SPECT). Mean SPECT septal perfusion defect size involved 9.5 +/- 6% of the left ventricle and correlated well with MCE area (r = 0.7), with no statistically significant difference between the risk area estimated by MCE and that by SPECT. CONCLUSIONS Estimation of the size of the septal vascular territory with MCE is accurate, safe and feasible in essentially all patients during NSRT. MCE can delineate the perfusion bed of the septal perforators and can predict the infarct size that follows ethanol injection.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Current status of nonsurgical septal reduction therapy in hypertrophic obstructive cardiomyopathy

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy patients has been available since 1994. Medium-term case series following alcohol septal ablation (ASA) are now available. Procedural risk is low and a significant improvement in symptom burden and left ventricular outflow tract gradient is observed in most cases. Success to medium-term is comparable to surgical se...

متن کامل

Detection of myocardial infarction by delayed contrast-enhanced multislice computed tomography.

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211–214. 2. Lakkis N, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III. Echocardiography-guided ethanol septal ablation for hypertrophic obstructive cardiomyopathy. Circulation 1998;98: 1750–1755. 3. Knight C. Alcohol septal ablation for obstructive hypertroph...

متن کامل

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.

OBJECTIVES This study was designed to compare the hemodynamic efficacy of nonsurgical septal reduction therapy (NSRT) by intracoronary ethanol with standard therapy (surgical myectomy) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM). BACKGROUND Nonsurgical septal reduction therapy has gained interest as a new treatment modality for patients with drug-refractory symptoms of...

متن کامل

Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy.

A47-year-old woman with hypertrophic obstructive cardiomyopathy presented with worsening exertional dyspnea, paroxysmal nocturnal dyspnea, and chest pain, despite maximal medical therapy. Echocardiography showed severe ventricular hypertrophy, left ventricular outflow tract (LVOT) narrowing, a 110 mm Hg LVOT gradient, and systolic anterior motion of the mitral valve. She was referred for nonsur...

متن کامل

Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Hypertrophic obstructive cardiomyopathy is the most common genetic cardiac disease and is generally characterised by asymmetric septal hypertrophy and intraventricular obstruction. Patients with severe obstruction and significant symptoms that persist despite optimal medical treatment are candidates for an invasive septal reduction therapy. Twenty years after its introduction, percutaneous tran...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of the American College of Cardiology

دوره 32 1  شماره 

صفحات  -

تاریخ انتشار 1998